For instance, isocitrate dehydrogenase (IDH) mutations often occur in low-grade gliomas, and the overall prognosis of patients with IDH mutations is better than that of wild-type patients (Cohen et al., 2013; Reuss et al., 2015). Here, IDH3A is linked to glioma.